Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901
(Adnkronos) – CHENGDU, China, Feb. 23, 2023 /PRNewswire/ — Keymed Biosciences Inc., (“Keymed”) (Stock Code: 02162 HK) and Lepu Biopharma Co., Ltd, (Stock Code: 02157.HK) today jointly announce a global exclusive licence
